PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,122 stories, page 177 of 619

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Inna Gruber Appointed Senior Director, Global Business Development at Lotus Pharmaceutical

hrtoday.inOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Qlife receives first revenue from pharmaceutical deal

BiostockOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Biotech Growth Trust PLC – LSE:BIOG

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vivace Therapeutics names new CEO as it prepares Phase 3 trial for mesothelioma drug

Proactive financial newsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical CDMO Market Size, Report 2026-2035

Global Market Insights Inc.Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Hansoh Pharmaceutical Group: Net profit surged 35.8% on double-digit revenue growth and strong innovative medicine sales

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lady Gaga reveals role at biotech Outer Bio

BioXconomyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves drug to treat HIV infection in newborns

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?

AOL.caOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical files for Phase 3 trial in Korea of biweekly obesity drug candidate ‘bofanglutide’

더바이오Original source
🌍discoverynews.google.comTier 3 · Aggregated media

HLB Therapeutics completes global Phase 3 trial of NK eye drop candidate ‘RGN-259,’ with topline results expected in November

더바이오Original source
🌍discoverynews.google.comTier 2 · Trade media

SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch

Fierce BiotechOriginal source
🇧🇪Regulatoryfamhp.beTier 1 · Regulatory source

Actualisering van de lijst van essentiële stoffen voor voedselproducerende paarden

FAMHP BelgiumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - GENB +15%, BDSX +10%, CDNA +6%, CPIX +10%, CRDL +7%

RTTNewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BlackRock Inc. Makes New Investment in Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Analysis of the health of Sellafield workers in the National Registry for Radiation Workers (NRRW)

The main aim of the NRRW is to evaluate the impact of radiation exposure on the risks from both canc...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

NRRW study information: guidance, privacy notice, governance group and publications

The National Registry for Radiation Workers (NRRW) is a long-term follow-up study of the health of r...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Guidance on expedited syphilis testing and treatment for inclusion health groups

Guidance for healthcare professionals working in settings and contexts where traditional healthcare...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Giardia: national laboratory data

Annual data of reported Giardia infections in England since 2007.

UK Health Security AgencyOriginal source
🇨🇭Industryinterpharma.chTier 1 · Company source

Die Schweiz verliert als klinischer Forschungsstandort zunehmend an Bedeutung

Interpharma SwitzerlandOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Australia Pharmaceutical Grade Sodium Carbonate - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SK Biopharmaceuticals invests 1.1t won, targets US with next-gen epilepsy drug - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Caliway’s CBL-514 Phase 2 Combination Trial Cleared; Phase 3 SUPREME-01 Enrolling

The Clinical Trial VanguardOriginal source
🌍Industrymonashhealth.orgTier 1 · Company source

Referring patients with suspected cardiac emergencies to the VHH

Monash HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Algert Global LLC Reduces Position in Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approval for Slimming Teas Weight Loss: What It Really Means and How to Use It Safely *bh4jSeiMO*

Villa de la OrotavaOriginal source
🌍Industrymonashhealth.orgTier 1 · Company source

Increased-risk aneuploidy screening results: referral changes

Monash HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Enwei Pharmaceutical Co., Ltd. Class A – SZSE:301331

TradingViewOriginal source
🇫🇮Researchhelsinki.fiTier 2 · Direct publisher

Olkapään rakenteellisia muutoksia löytyy lähes kaikilta yli 40-vuotiailta

Helsinki University ResearchOriginal source
🇯🇵Industrysumitomo-pharma.comTier 1 · Company source

Sumitomo Pharma Selected as a Constituent of the JPX Prime 150 Index

Sumitomo PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Consun Pharmaceutical Group: Revenue and profit surged, gross margin improved, and an interim dividend was declared

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MPSC Cancels Drug Inspector Recruitment Over Sweeping Paper Leak Scandal

streamlinefeed.co.keOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SK Biopharm strikes $800m deal for epilepsy drug from Biohaven

The Korea HeraldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmosa Biopharm's Partner Liquidia Ramps Up L606 Clinical Investment; Second-Half R&D Spending to Double

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wildland firefighters warned not to take supplements for smoke or PFAS exposure

wildfiretoday.comOriginal source
🌍Industrymonashhealth.orgTier 1 · Company source

Early Pregnancy Bleeding Clinic: now accepting eReferrals only

Monash HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tivicay: US FDA Approves Drug to Treat HIV In Newborns

Health and MeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Zhejiang CONBA Pharmaceutical Co., Ltd. Class A – SSE:600572

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

In Five Years, Will K-Pharma and Biotech Cross the 'Fortune 500' Threshold?

포춘코리아Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Ayub's at Fort in Mumbai loses food licence after FDA action

Time Out WorldwideOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

U.S. badly trails China in lowering barriers to biotech innovation

Genetic Literacy ProjectOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese Biotech Stocks Rally as Local Firms Advance Cancer Vaccines - News and Statistics

IndexBoxOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Baxter Issues Voluntary Nationwide Recall for Two Lots of 0.9% Sodium Chloride Injection Due to Potential Presence of Particulate Matter

FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is vol...

FDA MedWatchOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection System

ENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Flies, open drains, dirty kitchen: Popular Mumbai eatery Ayub's loses licence

India TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Daiko Pharmaceutical has applied to change its market segment to the Tokyo Stock Exchange Standard Market.

MoomooOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Emerging Biomarkers Shaping The Next Generation of Oncology Drug Development

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Winners And Losers Of Q2: Illumina (NASDAQ:ILMN) Vs The Rest Of The Life Sciences Tools & Services Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Healthcare Stocks Can Rally on Positive Clinical Trial Results

Analytics InsightOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What the FDA's Peptide Vote Actually Means

AOL.caOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mumbai: Ayub’s Among 4 Eateries To Lose Food Licence in Maharashtra FDA Crackdown

LatestLYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Natco to infuse $14 million in US biotech eGenesis

pharma.economictimes.indiatimes.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SK Biopharmaceuticals secures Biohaven epilepsy drug rights in $795m deal - CHOSUNBIZ

ChosunbizOriginal source